MSTT1041AAlternative Names: RO 7187807
Latest Information Update: 08 Nov 2016
At a glance
- Originator Roche
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Asthma
Most Recent Events
- 01 Sep 2016 Phase-II clinical trials in Asthma (Adjunctive treatment) in USA (SC) (NCT02918019)
- 01 Sep 2016 Preclinical trials in Asthma in USA (SC) before September 2016